Treatment Of Lung Hypertension Does Not Help Patients With Chronic Bronchitis
Main Category: Respiratory / AsthmaAlso Included In: Cardiovascular / Cardiology; Hypertension; COPD
Article Date: 29 Aug 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Patients with chronic smoker's bronchitis often suffer from increased pressure in the blood vessels supplying the lung (pulmonary hypertension). The blood pressure increases further during exercise and can lead to severe limitation of physical activity. In patients with other diseases causing pulmonary hypertension, for instance rheumatic or heart conditions, drug therapy has been shown to improve exercise capacity and decrease mortality.
Daiana Stolz (University Hospital Basel, Switzerland) and her colleagues wanted to find out whether patients with severe chronic bronchitis also benefit from treatment of pulmonary hypertension. They compared the effect of the lung vasodilator bosentan, a standard therapy for pulmonary hypertension, with the effect of placebo in 30 patients with severe chronic bronchitis. All patients underwent several tests including lung function and computed tomography before and after the three months of therapy.
The study shows that, in contrast to patients with other causes of pulmonary hypertension, chronic bronchitis patients do not improve their exercise capacity if treated with bosentan. This study also suggests that the treatment of pulmonary hypertension in patients with chronic bronchitis reduces the amount of oxygen in the blood. "Although we hoped to alleviate breathlessness by treating patients this way, we could not identify any benefit of the therapy," said Daiana Stolz.
Title Of The Original Article
A randomised, controlled trial of bosentan in severe COPD
The European Respiratory Journal is the peer-reviewed scientific publication of the European Respiratory Society (more than 8,000 specialists in lung diseases and respiratory medicine in Europe, the United States and Australia).
European Respiratory Journal
The European Respiratory Society (ERS)
Visit our respiratory / asthma section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/119354.php>
APA
http://www.medicalnewstoday.com/releases/119354.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




